BMRN compared with HPQ: revenue, margins and what each company keeps, and the suppliers and customers both name

BMRNBioMarin Pharmaceutical Inc

Mkt capRevenueRevenue

HPQHP Inc

Mkt capRevenueRevenue

Compare

BMRNBioMarin Pharmaceutical Inc

HPQHP Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

BMRN1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±8.2%▲+3.82%×0.46

HPQ

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±7.7%▼−2.92%×0.38

Q2 FY26±8.7%▼−1.88%×0.22

= impliedBMRN realized, solidHPQ realized, hatchedOne scale, both sides: full bar = 9%× = |realized| ÷ impliedSource: market data

Q1 FY26

±7.9%

▲+0.05%

×0.01

Q4 FY25±3.0%▲+4.32%×1.43

BMRNBioMarin Pharmaceutical Inc

58.53▲+1.81%· post 58.53

Mkt cap$11.3BRevenue$990MQ2 FY26Revenue$3.2BFY25

HPQHP Inc

28.78▼−9.58%· post 28.86

ClosedOct 30 '26

Mkt cap$26.0BRevenue$15.7BQ3 FY26Revenue$55.3BFY25

Compare

ClosedOct 30 '26

BMRNBioMarin Pharmaceutical Inc

HPQHP Inc

58.53▲+1.81%post 58.53

Price

28.78▼−9.58%post 28.86

$11.3B

Mkt cap

$26.0B

Q2 FY26$990M

Revenue

$15.7BQ3 FY26

FY25$3.2B

Revenue

$55.3BFY25

BMRN58.53▲+1.81%vsHPQ28.78▼−9.58%ClosedOct 30 '26